Gregory L. Weaver

Insider Reports History

Entity
Individual
Location
185 Berry Street, Suite 6504, San Francisco, California
Signature
/s/ Gregory L. Weaver
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory L. Weaver:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ATOSSA THERAPEUTICS, INC. Former EVP, CFO, & Director, Director Common Stock 55 $35.80 $0.65 Nov 15, 2023 Direct
ATOSSA THERAPEUTICS, INC. Former EVP, CFO, & Director, Director Stock Option (right to buy) 2.6M Jun 1, 2023 Direct
ATAI Life Sciences N.V. Chief Financial Officer Stock Option 228K Mar 2, 2022 Direct

Insider Reports Filed by Gregory L. Weaver

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ATOS ATOSSA THERAPEUTICS, INC. Nov 15, 2023 1 -$32.5K 4 Nov 17, 2023 Former EVP, CFO, & Director, Director
ATOS ATOSSA THERAPEUTICS, INC. Jun 20, 2023 1 $48.5K 4 Jun 20, 2023 EVP & CFO, Director
ATOS ATOSSA THERAPEUTICS, INC. Jun 1, 2023 1 $0 4 Jun 5, 2023 EVP & CFO, Director
ATOS ATOSSA THERAPEUTICS, INC. May 4, 2023 1 $0 4 May 5, 2023 Director
ATOS ATOSSA THERAPEUTICS, INC. May 13, 2022 1 $0 4 May 16, 2022 Director
ATAI ATAI Life Sciences N.V. Mar 2, 2022 1 $0 4 Mar 4, 2022 Chief Financial Officer
ATOS ATOSSA THERAPEUTICS, INC. Jul 2, 2021 10 -$600K 4 Jul 7, 2021 Director
ATAI ATAI Life Sciences N.V. Jun 22, 2021 1 $70K 4 Jun 24, 2021 Chief Financial Officer
ATAI ATAI Life Sciences N.V. Jun 17, 2021 1 $0 4 Jun 22, 2021 Chief Financial Officer
ATAI ATAI Life Sciences B.V. Jun 17, 2021 0 $0 3 Jun 17, 2021 Chief Financial Officer
ATOS ATOSSA THERAPEUTICS, INC. May 14, 2021 1 $0 4 May 18, 2021 Director